Enzyme replacement therapy for the sphingolipidoses.
D002518:Ceramides; D002554:Cerebrosides / Q000378:metabolism; D002517:Galactosylgalactosylglucosylceramidase / Q000627:therapeutic use; D005776:Gaucher Disease / Q000188:drug therapy / Q000378:metabolism; D005962:Glucosylceramidase / Q000627:therapeutic use; D006026:Glycoside Hydrolases / Q000627:therapeutic use*; D006801:Humans; D008064:Lipidoses / Q000188:drug therapy*; D008099:Liver / Q000378:metabolism; D013106:Sphingolipidoses / Q000188:drug therapy*; D013997:Time Factors
D002518:Ceramides; D002554:Cerebrosides; D006026:Glycoside Hydrolases; D005962:Glucosylceramidase; D002517:Galactosylgalactosylglucosylceramidase